The FirstTake Podcast – Deucravacitinib delivers as Big Pharma endures a tough Q1

FirstTake on Pharma - Pharma News and Analysis Podcast

English - April 29, 2021 23:00 - 17 minutes - 11.7 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The FirstTake Podcast – Bluebird Bio and Vertex provide contrasting gene therapy updates

Next Episode: The FirstTake Podcast – How much? – Pfizer reveals COVID-19 vaccine sales forecast

FirstWord Pharma PLUS editors Michael Flanagan, Simon King and Becky Simon discuss new Phase III data for Bristol Myers Squibb’s first-in-class psoriasis treatment deucravacitinib, the impact of the COVID-19 pandemic on Big Pharma’s first quarter performance and this week’s FDA AdCom meeting on accelerated cancer drug approvals.